Anticholinergic prescribing in hospitalised older adults: an uncontrolled before-and-after study of clinician education

Background Anticholinergic medications are associated with medication-related harm in older adults. Hospitalisation provides an opportunity to review prescribing, but evidence about clinician education alone remains uncertain. Objective To compare anticholinergic prescribing among hospitalised older adults during periods before and after clinician education. Methods This exploratory, single-site, uncontrolled retrospective before-and-after study included unique patients aged ≥65 years admitted for ≥24 h with medications documented at admission and discharge. Patient-level data were obtained for two 3-month periods before and after education was delivered to doctors and pharmacists. Outcomes were admission-to-discharge changes in Anticholinergic Cognitive Burden (ACB) score and number of anticholinergic medications. Linear regression estimated the adjusted mean between-period difference in discharge ACB. Results The study included 686 patients (368 pre-intervention; 318 post-intervention). Median ACB score decreased from admission to discharge in both periods (pre: 2 [IQR 1−4] to 1 [IQR 0–3], p = 0.002; post: 2 [IQR 1–3] to 1 [IQR 0–3], p = 0.004). The median number of anticholinergic medications remained 1 in both periods, although paired distributions shifted modestly downward (pre: p = 0.012; post: p = 0.005). The unadjusted mean difference in ACB change between periods was 0.025 points (bootstrap 95% CI −0.18 to 0.23); the Wilcoxon rank-sum p-value was 0.941. In the adjusted model, the post-intervention period was associated with a −0.064-point difference in discharge ACB (95% CI −0.265 to 0.137; p = 0.530). The between-period mean difference in anticholinergic-medication count change was −0.001 medications (bootstrap 95% CI −0.16 to 0.16); the Wilcoxon rank-sum p-value was 0.86. Conclusion Prescribed ACB decreased modestly and anticholinergic-medication count distributions shifted downward from admission to discharge in both periods, without evidence of additional adjusted between-period improvement. The uncontrolled design and incomplete implementation information preclude conclusions about the education program’s effectiveness. The findings can inform prospective evaluation of multimodal strategies.

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2026-11-11
DOI
https://doi.org/10.3389/fphar.2026.1933472
Primary Topic
Pharmaceutical Practices and Patient Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Anticholinergic prescribing in hospitalised older adults: an uncontrolled before-and-after study of clinician education

Gregory Mark Peterson, Daniel Jake Hoyle, Glen Bayer, Mohammed Saji Salahudeen et al.
Frontiers in Pharmacology
Pharmaceutical Practices and Patient Outcomes
article

Anticholinergic prescribing in hospitalised older adults: an uncontrolled before-and-after study of clinician education

Gregory Mark Peterson, Daniel Jake Hoyle, Glen Bayer, Mohammed Saji Salahudeen, Blair Adamczewski, Colin Michael Curtain, Woldesellassie M Mequanint Bezabhe, Crystal R. Ucarer, Duncan McKenzie
article en

Abstract

Background Anticholinergic medications are associated with medication-related harm in older adults. Hospitalisation provides an opportunity to review prescribing, but evidence about clinician education alone remains uncertain. Objective To compare anticholinergic prescribing among hospitalised older adults during periods before and after clinician education. Methods This exploratory, single-site, uncontrolled retrospective before-and-after study included unique patients aged ≥65 years admitted for ≥24 h with medications documented at admission and discharge. Patient-level data were obtained for two 3-month periods before and after education was delivered to doctors and pharmacists. Outcomes were admission-to-discharge changes in Anticholinergic Cognitive Burden (ACB) score and number of anticholinergic medications. Linear regression estimated the adjusted mean between-period difference in discharge ACB. Results The study included 686 patients (368 pre-intervention; 318 post-intervention). Median ACB score decreased from admission to discharge in both periods (pre: 2 [IQR 1−4] to 1 [IQR 0–3], p = 0.002; post: 2 [IQR 1–3] to 1 [IQR 0–3], p = 0.004). The median number of anticholinergic medications remained 1 in both periods, although paired distributions shifted modestly downward (pre: p = 0.012; post: p = 0.005). The unadjusted mean difference in ACB change between periods was 0.025 points (bootstrap 95% CI −0.18 to 0.23); the Wilcoxon rank-sum p-value was 0.941. In the adjusted model, the post-intervention period was associated with a −0.064-point difference in discharge ACB (95% CI −0.265 to 0.137; p = 0.530). The between-period mean difference in anticholinergic-medication count change was −0.001 medications (bootstrap 95% CI −0.16 to 0.16); the Wilcoxon rank-sum p-value was 0.86. Conclusion Prescribed ACB decreased modestly and anticholinergic-medication count distributions shifted downward from admission to discharge in both periods, without evidence of additional adjusted between-period improvement. The uncontrolled design and incomplete implementation information preclude conclusions about the education program’s effectiveness. The findings can inform prospective evaluation of multimodal strategies.

Frontiers in PharmacologyVol. 17
University of Tasmania (AU), Royal Hobart Hospital (AU)
Pharmaceutical Practices and Patient Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon